Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
298
-
Total 13F shares, excl. options
-
83.2M
-
Shares change
-
+3.23M
-
Total reported value, excl. options
-
$1.19B
-
Value change
-
+$44.6M
-
Put/Call ratio
-
0.05
-
Number of buys
-
99
-
Number of sells
-
-170
-
Price
-
$14.27
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q4 2023
362 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q4 2023.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 298 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 83.2M shares
.
Largest 10 shareholders include Capital Research Global Investors (14.3M shares), Mondrian Investment Partners LTD (8.17M shares), MILLENNIUM MANAGEMENT LLC (6.49M shares), MORGAN STANLEY (4.85M shares), GOLDMAN SACHS GROUP INC (4.3M shares), RENAISSANCE TECHNOLOGIES LLC (3.33M shares), BRANDES INVESTMENT PARTNERS, LP (2.65M shares), MACQUARIE GROUP LTD (2.45M shares), FMR LLC (2.18M shares), and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (1.91M shares).
This table shows the top 298 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.